Compact Cas12m is an enabling technology, not an aging treatment

Structure-guided engineering produced a compact DNA-binding system and epigenetic regulation in human cells, with a silencing application in a mouse hepatitis B model. The central contribution is regulator size and control.

Compare in the Atlas

Concept illustration / not experimental evidence

What was reported

What the result does not establish

The system is Cas12m, not Cas9. A successful viral-disease model does not establish delivery or rejuvenation in aged muscle, brain or other tissues.

Measured endpoint

Gene regulation and silencing in the reported cell and disease-model settings.

Karam’s next question

Does compactness solve a real delivery constraint after a biological target and tissue have been selected?

Assessment-derived brief. Cited in the supplied 15 October 2026 project assessment; not independently reviewed in this website release. Karam has not reproduced the experiment or independently audited the underlying dataset. This is not Karam-generated evidence.

Record transparency

The details—and the missing values.

Extraction scope: supplied project assessment, not an independent full-methods extraction
Study date	2026-09-16
Reported region	China
Species / biological system	Human cells; mouse disease model
Target / subject	xCas12m / experimental silencing targets
Cell or population context	Human-cell experiments; mouse hepatitis B model
Perturbation direction	Gene regulation / silencing
Method	Epigenome editing
Delivery setting	AAV delivery in the reported mouse application
Comparator	Not extracted in the supplied assessment; review the primary source before using this field.
Donor context	Not extracted in the supplied assessment; review the primary source before using this field.
Sample size / unit	Not extracted in the supplied assessment; review the primary source before using this field.
Follow-up	Not extracted in the supplied assessment; review the primary source before using this field.
Safety measurements	Not extracted in the supplied assessment; review the primary source before using this field.
Independent replication	Not established in the supplied assessment
Data access	Not extracted in the supplied assessment; review the primary source before using this field.

What would this evidence change?

Use the context in this record to define a bounded research or diligence question. A cited finding is not a validated Karam asset.

Discuss a scope Explore the Atlas